Stryker Corporation (SYK) support and resistance · P/E 35, rev $6.59B
Stryker Corporation (SYK) is a medical devices company listed on NYSE.
This page maps Stryker Corporation (SYK) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported SYK revenue for 2026-06-30 was $6.59B. Net income was $1.28B. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
SYK currently screens at market cap $115.45B and trailing P/E 34.9. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new SYK 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the SYK quote page for the session range and the stock page for the full model.
Not investment advice.